Clinical Trials Directory

Trials / Completed

CompletedNCT00529594

Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The study wants to show if the medication etoricoxib 120 mg have reduces the patients pain during the laser photocoagulation, for diabetic retinopathy.

Detailed description

To do so we compare two group of patients, randomized 1:1, one use the medication(etoricoxib) and other use placebo and they quantify the pain using the Pain visual analogue scale

Conditions

Interventions

TypeNameDescription
DRUGplacebo (Control Group)Both medication have been given to the patients in both groups 1 hour prior the laser photocoagulation
DRUGEtoricoxib (Treatment Group)Both medication have been given to the patients in both groups 1 hour prior the laser photocoagulation

Timeline

Start date
2006-08-01
Completion
2006-11-01
First posted
2007-09-14
Last updated
2007-09-14

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00529594. Inclusion in this directory is not an endorsement.

Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation (NCT00529594) · Clinical Trials Directory